Authors: GALASKO D CHANG L MOTTER R CLARK CM KAYE J KNOPMAN D THOMAS R KHOLODENKO D SCHENK D LIEBERBURG I MILLER B GREEN R BASHERAD R KERTILES L BOSS MA SEUBERT P

Citation: D. Galasko et al., HIGH CEREBROSPINAL-FLUID TAU AND LOW AMYLOID BETA-42 LEVELS IN THE CLINICAL-DIAGNOSIS OF ALZHEIMER-DISEASE AND RELATION TO APOLIPOPROTEIN-EGENOTYPE, Archives of neurology, 55(7), 1998, pp. 937-945

Authors: SEUBERT PA MOTTER RN SCHENK DB LIEBERBURG IM KHOLODENKO D GALASKO D THOMAS R CHANG L MILLER B CLARK C KNOPMAN DS KAYE J GREEN RC KERTILES L BASHIRZADEH R BOSS MA

Citation: Pa. Seubert et al., APOE GENOTYPE INFLUENCES THE CSF LEVEL OF A-BETA-42 IN ALZHEIMERS-DISEASE, Neurology, 48(3), 1997, pp. 63006-63006

Authors: ANANTH UA JONES JG FAFEL KC SELTZER WK STGEORGEHYSLOP PH BOSS MA

Citation: Ua. Ananth et al., THE DEVELOPMENT OF PRESENILIN-1 (PS-1) AS A CLINICAL DIAGNOSTIC-TEST FOR EARLY-ONSET FAMILIAL ALZHEIMERS-DISEASE, American journal of human genetics, 61(4), 1997, pp. 1255-1255

Authors: BOSS MA LOWTHER MA

Citation: Ma. Boss et Ma. Lowther, FACTORS INFLUENCING CURRICULUM CHANGE IN PROFESSIONAL PROGRAMS, Review of higher education, 18(2), 1995, pp. 235-235

Authors: BOSS MA ANANTH U PAQUET D MURPHY PD

Citation: Ma. Boss et al., A RETROSPECTIVE STUDY OF 47 PATIENTS WITH HIGHLY ELEVATED ANTI-GM(1) ANTIBODIES, Muscle & nerve, 18(1), 1995, pp. 128-129